{"format":1,"id":"118-hr-9598","congress":118,"number":"H.R. 9598","kind":"bill","group":"bills","title":"Office of National Drug Control Policy Reauthorization Act of 2024","title_source":"Short Title(s) as Passed House","official_title":"To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes.","titles":[{"type":"Official Title as Introduced","title":"To amend the Office of National Drug Control Policy Reauthorization Act to reauthorize such Office, and for other purposes."},{"type":"Short Titles from RFS (Referred to Senate) bill text","title":"Office of National Drug Control Policy Reauthorization Act of 2024"},{"type":"Short Title(s) as Passed House","title":"Office of National Drug Control Policy Reauthorization Act of 2024"},{"type":"Display Title","title":"Office of National Drug Control Policy Reauthorization Act of 2024"},{"type":"Short Title(s) as Introduced","title":"Office of National Drug Control Policy Reauthorization Act of 2024"}],"outcome":"passed_house","law_number":null,"introduced":"2024-09-16","chambers":{"house":{"status":"roll_call","date":"2024-12-05","vote":{"id":"118-2024-h485","question":"On Motion to Suspend the Rules and Pass, as Amended","title":"Office of National Drug Control Policy Reauthorization Act","result":"Passed","yea":399,"nay":1,"present":0,"not_voting":32,"source":"https://clerk.house.gov/evs/2024/roll485.xml"}},"senate":{"status":"na","date":null,"vote":null}},"president":{"status":"na","date":null},"vice_president_tie_breaker":null,"latest_action":{"text":"Received in the Senate and Read twice and referred to the Committee on the Judiciary.","date":"2024-12-09"},"nominees":null,"amendments":[],"other_votes":[],"crs_summary":{"date":"2024-09-16","stage":"Introduced in House","blocks":[{"k":"h","t":"Office of National Drug Control Policy Reauthorization Act of 2024"},{"k":"p","t":"This bill reauthorizes through FY2031 the Office of National Drug Control Policy and related grants, programs, and initiatives such as"},{"k":"li","t":"the High Intensity Drug Trafficking Areas program,","d":1},{"k":"li","t":"the Drug-Free Communities program,","d":1},{"k":"li","t":"the Drug Court Training and Technical Assistance program, and","d":1},{"k":"li","t":"the National Community Anti-Drug Coalition Institute.","d":1}],"words":56},"summary":{"main_subject":{"text":"Amends the Office of National Drug Control Policy Reauthorization Act of 1998 and related laws to extend the Office of National Drug Control Policy's authorizations and funding amounts through fiscal year 2031, and to add new reporting requirements.","cites":[{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}]},"core_areas":["Office of National Drug Control Policy reauthorization and funding amounts","High Intensity Drug Trafficking Areas grants and fentanyl interdiction","Community anti-drug coalition grants and the National Community Anti-Drug Coalition Institute","Opioid overdose reversal agents such as naloxone","Drug control data, strategy and reporting requirements"],"what_it_does":[{"text":"Adds $298,579,000 for each of fiscal years 2025 through 2031 to the list of funding amounts in section 707 of the Office of National Drug Control Policy Reauthorization Act of 1998.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}},{"text":"Requires that not less than $5,000,000 of the grant amounts allocated under section 707(s) go to fentanyl seizure and interdiction grants, and lets the Attorney General temporarily reassign assistant United States attorneys to prioritize fentanyl trafficking cases.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}},{"text":"Requires the Director of the Office of National Drug Control Policy to report to Congress within 180 days on the availability of overdose reversal medications such as naloxone, including a strategy for State, local and Tribal governments.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}},{"text":"Requires a Caribbean Border Counternarcotics Strategy on preventing drug trafficking through the Caribbean region, including content specific to Puerto Rico and the United States Virgin Islands.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}},{"text":"Provides $109,000,000 for each of fiscal years 2025 through 2031 under section 1024(a) of the Anti-Drug Abuse Act of 1988 and raises the coalition grant figure in section 1032(b) from $125,000 to $150,000.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}},{"text":"Requires the Director of the Office of Drug Control Policy to make public, within 120 days, a report analyzing and describing strategic ways to regulate the shipment of pill press machines and their parts.","cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"}}],"unexpected":[{"category":"named_funding","items":[{"cite":{"label":"Sec. 2","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh#HD259B5436DEE48B49AB355383C6FD2BB"},"heading":"Office of National Drug Control Policy Reauthorization","effect":"Directs the Director to disburse $2,500,000 for each of fiscal years 2025 through 2031 for the National Community Anti-Drug Coalition Institute, using amounts authorized under section 1024 of the Anti-Drug Abuse Act of 1988.","amount":"$2,500,000","quote":"disburse $2,500,000 made available under subsection (a), for each of the fiscal years 2025 through 2031"}]}],"version":{"type":"Engrossed in House","date":"2024-12-05","rule":"passed","href":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text/eh"},"current":true,"model":"claude-sonnet-5-5","approved":"2026-09-30","approved_by":"checks"},"sources":{"congress_gov":"https://www.congress.gov/bill/118th-congress/house-bill/9598","text":"https://www.congress.gov/bill/118th-congress/house-bill/9598/text"},"card":{"image":"card/item/118-hr-9598.png","v":"9ba7d19b858f","alt":"Votes on Record. H.R. 9598, 118th Congress: Office of National Drug Control Policy Reauthorization Act of 2024. House: 399 Yea, 1 Nay. Outcome: Passed House, 5 Dec 2024."}}